Sharemaestro company-news research for Vericel Corp Ord (VCEL), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQUnited StatesProvisional evidence
Company news sentiment
Latest VCEL news and sentiment
Vericel Corp Ord
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
SectorHealthcarewider market groupIndustryBiotechnologycompany peer groupLatest weekly closeUSD 40.10week of 9 Oct 2026Main news subjectBalance sheet58/100 share of current newsNews data statusPartial2 duplicate stories removed
Current company news
Early balanced news score
2 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
2 current stories are mapped specifically to VCEL.
What limits the score
Source breadth
Only 1 publisher currently contribute to the measured read.
Too little evidence
The stories agree, but freshness-weighted evidence is only 0.025.
Confidence
Confidence is 16/100, below the threshold for a firm score.
50/100
News scoreEarly balanced news score
16/100
Confidencethin evidence
78%/100
Company news2 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
Daily weighted evidence ยท gaps mean no reading
14 Sep29 Sep13 Oct
News scoreStory count50 baseline
Confidence
How reliable the score is
Separate from direction
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence0
0.025 after freshness weighting
Source breadth20
1 independent publishers
Company relevance78
share tied directly to this company
Freshness5
recency-weighted evidence
Agreement100
how closely stories agree
Publisher mix0
less reliance on one publisher
Price and news history
Weekly price and news-score history
Early company-news score
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
17 Apr14 Jul09 Oct
Weekly close, indexedSentiment score
26-week price+12.4%latest close 40.10News score change-5first to latest comparable weekOne-week response-0.1%Price digestingFair-value position-5.2%Near fair-value range
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move-555 to 50 ยท WeakeningObserved range50โ6850 is the neutral baselineEvidence depth2stories at latest stored reading ยท +1Confidence16/100Provisional ยท -15
07 May50 neutral11 Oct 16:51
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
Observed
Score
Move
Confidence
Stories
Status
11 Oct 16:51
50
-1
16/100 (-12)
2 (-2)
Provisional
26 Sep 23:59
51
+1
28/100 (+13)
4 (-1)
Provisional
16 Sep 23:59
50
+0
15/100 (0)
5 (-8)
Provisional
08 Sep 23:59
50
+0
15/100 (0)
13 (+1)
Provisional
07 Sep 23:59
50
-4
15/100 (-13)
12 (-27)
Provisional
21 Aug 23:59
54
+0
28/100 (-3)
39 (0)
Provisional
18 Aug 23:59
54
+0
31/100 (-3)
39 (0)
Provisional
15 Aug 23:59
54
+0
34/100 (+3)
39 (-1)
Provisional
Evidence behind the direction
What drives this reading?
1 directional stories ยท 1 publisher groups
Shares of weighted directional evidence in 2 retained current headlines. These weights already account for freshness, relevance and publisher limits; they are not additive points of the published score.
Which subjects lean each way
A subject can carry both supportive and cautious news.
SubjectCautious โ 0 โ Constructive
Balance sheet1 story
0.0%100.0%
Each side uses the same scale: 0โ100.0% of the retained directional evidence.
Where the influence comes from
100.0%largest publisher share
A concentrated reading can depend heavily on one publisher.
Simply Wall St.1 story100.0%
Publisher groups follow the scoring rules. Company disclosures share one group; syndicated stories are consolidated before weighting.
Source headlines
The news behind the score
Showing 1-2 of 2
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
Vericel has delivered a solid 31.4% share price gain over the past year, which naturally puts a spotlight on whether that move lines up with the cash the business is expected to generate. With the stock last closing at US$39.71, the key issue for you is whether that market value can be reโฆ
100% of directional evidenceMedium story strength
Scoring detailsDirect company coverage
Vericel has delivered a solid 31.4% share price gain over the past year, which naturally puts a spotlight on whether that move lines up with the cash the business is expected to generate. With the stock last closing at US$39.71, the key issue for you is whether that market value can be reconciled with what its cash flows imply through a Discounted Cash Flow (DCF) lens. The 31.4% one year return has rewarded existing holders, so any fresh money coming in now needs a clear view on what the underlying cash generation can support. Vericel's ability to turn its current product portfolio and operati
This article provides the transcript of Vericel Corporation's presentation at the Morgan Stanley Global Healthcare Conference on September 15, 2026. CEO Nick Colangelo and CFO Joe Mara discussed Macy, their lead product for cartilage repair, including updates on its international launch pโฆ
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
This article provides the transcript of Vericel Corporation's presentation at the Morgan Stanley Global Healthcare Conference on September 15, 2026. CEO Nick Colangelo and CFO Joe Mara discussed Macy, their lead product for cartilage repair, including updates on its international launch preparations and a trial for ankle application. The conference provided an opportunity to highlight ongoing initiatives driving the company's growth.
Published
16 Sep 2026 15:56
News subject
Market update
Why this score
No clear directional signal in the available text
Company focus
Shared story ยท 78%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 27.2d old
Text assessed
Stored article
Duplicates
1 consolidated
EarningsLife Sciences
Earlier company news
VCEL news archive
62 older headlines
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 62 older VCEL headlines. Open one page at a time when you need them.
A news provider linked these stories to VCEL, but the headline and available text are not mainly about Vericel Corp Ord. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of VCEL sentiment.
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence is separate
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme. This is a rule-based evidence measure, not a calibrated probability.
Price is confirmation
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
What the page does
It measures news already published. It is not a forecast, recommendation or price target.
Search markets
Search by ticker symbol or company name and select a result to open its chart.
Markets includedUnited States
Start typing to find a stock or ETF.
Market search
Choose countries
Choose one or more countries for market search, or include every covered market.
Currently searching United States
Sharemaestro
Send a message
Ask about our research, get help with the site, or send a correction.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.